Patents by Inventor Sarah McQuaid

Sarah McQuaid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120231533
    Abstract: A chamber device for analyzing living cell(s). The chamber device includes a base and a lid that when reversibly pressed closed create a chamber. The base is configured with an optically transparent well to contain at least one cell. The lid has a breadth greater than the base and is configured to contain at least one sensor. The lid is further configured with a lip that when pressed between the lid and the base creates an impermeable seal. The base and the lid are configured so that, when closed and in use, the sensor remains spatially apart from the at least one cell.
    Type: Application
    Filed: October 28, 2009
    Publication date: September 13, 2012
    Inventors: Mark R. Holl, Deirdre R. Meldrum, A. Cody Youngbull, Haixin Zhu, Jeff Houkal, Yanqing Tian, Shashanka Ashili, Laimonas Kelbauskas, Roger Johnson, Shih-hui Chao, Peter Wiktor, Alex Jen, Lloyd Burgess, Sarah McQuaid, Ai Brunner, Peter Kahn
  • Patent number: 7928060
    Abstract: The present invention relates to Amylin Family Polypeptide-6 (AFP-6) analogs, which include derivatives and fragments, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the AFP-6 analogs. The AFP-6 analogs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent conditions such as metabolic and cardiovascular disorders, e.g., obesity, diabetes, metabolic syndrome, myocardial ischemia, and increased cardiovascular risk.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: April 19, 2011
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Mary Erickson, Ved Srivastava, Sarah McQuaid, Andrew Young, Richard Pittner, Soumitra Ghosh
  • Publication number: 20080207501
    Abstract: The present invention relates to Amylin Family Polypeptide-6 (AFP-6) analogs, which include derivatives and fragments, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the AFP-6 analogs. The AFP-6 analogs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent conditions such as metabolic and cardiovascular disorders, e.g., obesity, diabetes, metabolic syndrome, myocardial ischemia, and increased cardiovascular risk.
    Type: Application
    Filed: October 11, 2005
    Publication date: August 28, 2008
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Mary Erickson, Ved Srivastava, Sarah McQuaid, Andrew A. Young, Richard A. Pittner, Soumitra S. Ghosh